The IBSAL Cancer Research Unit comprises 18 research groups: 11 of them are well established, 5 are emerging and 2 are associated clinical research groups. The unit co-leaders are Dra María Victoria Mateos Manteca and Dr Pedro Alfonso Lazo-Zbibowski Taracena.
- CANC-01 Study on the disposition and treatment of solid tumours
- CANC-03 Multiple myeloma and new drugs
- CANC-04 Molecular genetics in onco-haematology
- CANC-05 Molecular and cellular biology of haematological disorders
- CANC-06 Surgery and cancer
- CANC-08 GRUMUR: Urology multidisciplinary research group
- CANC-09 Tumour genetics
- CANC-10 Redox signalling in haematologic neoplasia
- CANC-11 Cytomics
- CANC-13 Identification of the genetic variants in the susceptibility, development and treatment of cancer
- CANC-14 Bioinformatics and functional genomics
- CANC-15 Stem cells, cancer stem cells and the biology of cancer
- CANC-16 Signalling and cancer
- CANC-17 Microenvironment in multiple myeloma and bone lesions
- CANC-18 Cellular signalling and DNA damage in cancer and neurodegeneration
- CANC-22 Radiation therapy oncology
- CANC-24 Molecular and cellular oncology lab